APL Sales I LLC
Waltham, MA Part of Apellis Pharmaceuticals, Inc.
- UEI
- XXKJSCZRL266
- CAGE
- 8XB84
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
K5MJXKU48NA9
-
Parent
K5MJXKU48NA9
- SAM.gov registration date
- Physical address
- 100 5th Ave Fl 3, Waltham, MA 02451, USA
- Website
- apellis.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $155,762 |
| FY2024 | $334,507 |
| FY2023 | $255,857 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Empaveli 1080 MG | Veterans Integrated Service Network 5 (VHA) | $26,219 | |
| Empaveli 1080 MG | Veterans Integrated Service Network 5 (VHA) | $26,219 | |
| Empaveli 1080 MG | Veterans Integrated Service Network 5 (VHA) | $25,831 | |
| Empaveli 1080 MG | Veterans Integrated Service Network 5 (VHA) | $25,831 | |
| Empaveli 1080 MG | Veterans Integrated Service Network 5 (VHA) | $25,831 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Incyte Corporation | Wilmington, DE | 325412 Pharmaceutical Preparation Manufacturing |
| Alexion Pharmaceuticals Inc. | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Mirum Pharmaceuticals, Inc. | San Mateo, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Xeris Pharmaceuticals, Inc. | Chicago, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
About the company
APL Sales I LLC is a subsidiary of Apellis Pharmaceuticals, Inc., a biopharmaceutical company focused on developing specialized pharmaceutical treatments for rare diseases. Registered in SAM.gov since March 2021, the company is a for-profit limited liability company structured as a corporate entity that provides pharmaceutical products to federal agencies, primarily the Department of Veterans Affairs (VA). As a child entity of Apellis Pharmaceuticals, APL Sales I LLC specializes in delivering targeted pharmaceutical medications, with a particular focus on drugs used to treat rare medical conditions.
Through its federal contract awards, APL Sales I LLC has consistently provided the drug EMPAVELI 1080 MG, a complement C3 inhibitor used to treat paroxysmal nocturnal hemoglobinuria, a rare blood disorder. These pharmaceutical delivery orders have been exclusively awarded by the VA's Veterans Health Administration, specifically through the Veterans Integrated Service Network 5, covering western Pennsylvania and parts of West Virginia. The contracts are uniformly structured as firm fixed-price delivery orders, typically valued between $25,000 and $26,000, and have short performance periods ranging from one to two weeks. No set-aside designations have been used in these contract awards, and APL Sales I LLC has been the prime contractor for these pharmaceutical supply contracts.
APL Sales I LLC holds two significant federal contract indefinite delivery vehicles (IDVs) with the VA. The first is a single-award Blanket Purchase Agreement (BPA) with a $2 million ceiling value, awarded by the VA National Acquisition Center, which runs through March 29, 2026 and covers the provision of EMPAVELI. The second is a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a $225,000 ceiling value and an ultimate completion date of December 14, 2026. Both IDVs were awarded without set-aside designations and provide streamlined procurement mechanisms for the VA to obtain critical pharmaceutical products. These contract vehicles enable APL Sales I LLC to deliver specialized medications like EMPAVELI and Empagliflozin to support veterans' healthcare services across multiple VA medical facilities.
Quick answers
Is APL Sales I LLC registered in SAM.gov?
Yes. APL Sales I LLC's SAM.gov registration is active through April 15, 2027.
Which contract vehicles does APL Sales I LLC hold?
APL Sales I LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has APL Sales I LLC received in federal contracts?
Federal contracts obligated $155,762 to APL Sales I LLC in fiscal year 2025 and $746,127 in fiscal years 2023 through 2027.
What is APL Sales I LLC's most recent federal award?
APL Sales I LLC's most recent federal contract award is Empaveli 1080 MG (36C24525N0408), from Veterans Integrated Service Network 5 (VHA), on February 25, 2025.
On GovTribe
See APL Sales I LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors